Cargando…
Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2
The pandemic caused by SARS-CoV-2 has led to the successful development of effective vaccines however the prospect of variants of SARS-CoV-2 and future coronavirus outbreaks necessitates the investigation of other vaccine strategies capable of broadening vaccine mediated T-cell responses and potenti...
Autores principales: | Piadel, Katarzyna, Haybatollahi, Amin, Dalgleish, Angus George, Smith, Peter Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895615/ https://www.ncbi.nlm.nih.gov/pubmed/35014605 http://dx.doi.org/10.1099/jgv.0.001698 |
Ejemplares similares
-
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
por: Smith, Peter Lawrence, et al.
Publicado: (2021) -
SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021) -
Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
por: Davies, Katherine, et al.
Publicado: (2021) -
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection
por: Henss, Lisa, et al.
Publicado: (2021) -
ARF6 is a host factor for SARS-CoV-2 infection in vitro
por: Mirabelli, C., et al.
Publicado: (2023)